The Department of Homeland Security (DHS) published a warning about Medtronic implantable defibrillators and the vulnerabilities in the devices, which could potentially allow them to be hacked by nearby attackers....
Medtechy Deals Spotlight: This #Wireless Charging Powerhouse Says Sayonara to Stray Cables | https://t.co/w8yPDitCHE pic.twitter.com/bLFj5zKYa6
— medtech[y] (@medtechy) March 21, 2019
Apple recently announced the results of the Apple Heart Study, which was led by physicians at Stanford Medicine. The study enrolled over 400,000 participants in an effort to evaluate Apple Watch's irregular rhythm notification....
Building a culture at a startup, large organization or even a small sales team needs to be handled with care and thoughtfulness. Hiring one bad apple could impact how your company performs and gains traction in the market....
With their stock down over 94% in the last year, Nevro finally pulled the trigger and made a change at the top with Rami Elghandour stepping down and being replaced with D. Keith Grossman who will be appointed as Nevro's CEO and a member of the Board of Directors....
AbbVie announced this morning that the FDA has put a partial clinical hold on all clinical trials evaluating venetoclax, specifically for the investigational treatment of multiple myeloma....
Boston Scientific was down more than 5% on positive Edwards' Sapien 3 data presented on Sunday, March, 17, at the American College of Cardiology meeting. Edwards' stock was up almost 7% at the time of writing....
According to the Department of Justice, Covidien, now part of Medtronic, has agreed to pay approximately $20 million to resolve False Claim Act allegations....
Stryker ($SYK) announced they are acquiring OrthoSpace for up to $220 million. The all cash deal includes an upfront payment of $110 million and future milestone payments of up to an additional $110 million....
Originally approved in 2013 for patients with mitral valve abnormalities who are not suitable for mitral valve surgery, Abbott's MitraClip was given the FDA ok for expanded use today....